marketwatch: "new migraine drugs have promise -- and a ,500 price tag."..

lawmakers should revisit that idea when lepage is no longer in office next year...

  • .
    • ...

      "we were quite surprised to find there were no significant differences," says study author..3000.

    • .

      it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..